Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen ReceptorAshley T. Fancher(University of Pittsburgh), Paul A. Johnston(University of South Carolina)Assay and Drug Development TechnologiesSeptember 10, 201910.1089/adt.2019.940Cited by 8SaveCiteExport RISWatch citationsRelated PapersDetection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines|SLAS DISCOVERY|2022|37